Howell L L, Byrd L D
Yerkes Regional Primate Research Center, Emory University, Atlanta, Georgia.
J Pharmacol Exp Ther. 1992 Sep;262(3):907-15.
The behavioral effects of cocaine (0.03-3.0 mg/kg i.v.) were determined in squirrel monkeys (Saimiri sciureus) trained to respond under a fixed-interval 300-sec schedule of stimulus termination. A session consisted of 13 consecutive fixed-interval components, each followed by a 60-sec timeout. Graded doses of cocaine were injected during selected timeout periods using a cumulative-dosing procedure. Subsequently, two dopamine D2-selective antagonists, spiperone and raclopride, and a D1-selective antagonist, SCH 23390, were administered chronically for a 2-week period. Due to pronounced time course differences, raclopride and SCH 23390 were infused continuously via osmotic minipump, and spiperone was administered i.m. twice per week. Spiperone and raclopride markedly suppressed responding during the 2-week period. When the effects of cocaine were redetermined 3 days after spiperone or 1 day after raclopride administration was terminated, there was a parallel leftward shift in the dose-effect curve, indicating enhanced sensitivity to cocaine. Three days later, sensitivity to cocaine had changed and was similar to that obtained before chronic drug administration. In contrast, SCH 23390 did not alter sensitivity to cocaine after chronic administration was terminated, even though it did attenuate the behavioral effects of cocaine as effectively as spiperone and raclopride. Chronic administration of spiperone did not alter sensitivity to nisoxetine, a norepinephrine uptake inhibitor, or quipazine, a serotonin agonist. The acute administration of spiperone in combination with cocaine also differed markedly from nisoxetine and quipazine. The pronounced rate-decreasing effect of spiperone was attenuated by cocaine in a dose-dependent manner, but not by nisoxetine or quipazine.(ABSTRACT TRUNCATED AT 250 WORDS)
在接受固定间隔300秒刺激终止时间表训练的松鼠猴(Saimiri sciureus)中,测定了可卡因(静脉注射0.03 - 3.0毫克/千克)的行为效应。一次实验由13个连续的固定间隔部分组成,每个部分之后是60秒的超时阶段。在选定的超时阶段使用累积给药程序注射分级剂量的可卡因。随后,两种多巴胺D2选择性拮抗剂,螺哌隆和雷氯必利,以及一种D1选择性拮抗剂,SCH 23390,进行了为期2周的长期给药。由于明显的时间进程差异,雷氯必利和SCH 23390通过渗透微型泵持续输注,螺哌隆每周肌肉注射两次。在为期2周的时间里,螺哌隆和雷氯必利显著抑制了反应。在停止注射螺哌隆3天后或雷氯必利1天后重新测定可卡因的效应时,剂量 - 效应曲线出现平行向左移动,表明对可卡因的敏感性增强。三天后,对可卡因的敏感性发生了变化,与长期给药前相似。相比之下,尽管SCH 23390与螺哌隆和雷氯必利一样有效地减弱了可卡因的行为效应,但在长期给药终止后,它并未改变对可卡因的敏感性。长期给予螺哌隆并未改变对去甲肾上腺素摄取抑制剂尼索西汀或5-羟色胺激动剂喹哌嗪的敏感性。螺哌隆与可卡因联合急性给药也与尼索西汀和喹哌嗪明显不同。螺哌隆显著的降低速率效应被可卡因以剂量依赖性方式减弱,但未被尼索西汀或喹哌嗪减弱。(摘要截断于250字)